CA2456175A1 - Benzoquinone ansamycins - Google Patents

Benzoquinone ansamycins Download PDF

Info

Publication number
CA2456175A1
CA2456175A1 CA002456175A CA2456175A CA2456175A1 CA 2456175 A1 CA2456175 A1 CA 2456175A1 CA 002456175 A CA002456175 A CA 002456175A CA 2456175 A CA2456175 A CA 2456175A CA 2456175 A1 CA2456175 A1 CA 2456175A1
Authority
CA
Canada
Prior art keywords
ethyl
substituted
unsubstituted
group
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002456175A
Other languages
English (en)
French (fr)
Inventor
Daniel Santi
David C. Myles
Zong-Qiang Tian
C. Richard Hutchinson
Robert Johnson
Yi-Qing Zhou
Li Feng
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kosan Biosciences Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority claimed from PCT/US2002/024891 external-priority patent/WO2003013430A2/en
Publication of CA2456175A1 publication Critical patent/CA2456175A1/en
Abandoned legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA002456175A 2001-08-06 2002-08-05 Benzoquinone ansamycins Abandoned CA2456175A1 (en)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US31077901P 2001-08-06 2001-08-06
US60/310,779 2001-08-06
US38925502P 2002-06-14 2002-06-14
US60/389,255 2002-06-14
US39392902P 2002-07-03 2002-07-03
US60/393,929 2002-07-03
US39527502P 2002-07-12 2002-07-12
US60/395,275 2002-07-12
PCT/US2002/024891 WO2003013430A2 (en) 2001-08-06 2002-08-05 Benzoquinone ansamycins

Publications (1)

Publication Number Publication Date
CA2456175A1 true CA2456175A1 (en) 2003-02-20

Family

ID=32475692

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002456175A Abandoned CA2456175A1 (en) 2001-08-06 2002-08-05 Benzoquinone ansamycins

Country Status (2)

Country Link
JP (1) JP2005515164A (https=)
CA (1) CA2456175A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0418147A (pt) * 2003-12-23 2007-04-17 Infinity Pharmaceuticals Inc análogos de ansamicinas contendo benzoquinona e seus métodos de uso
JP5681719B2 (ja) * 2009-09-24 2015-03-11 アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル タウ機能不全を伴う神経障害を処置するための新規な治療ターゲットとしてのｆｋｂｐ５２−タウ相互作用

Also Published As

Publication number Publication date
JP2005515164A (ja) 2005-05-26

Similar Documents

Publication Publication Date Title
US6872715B2 (en) Benzoquinone ansamycins
EP1420747A2 (en) Benzoquinone ansamycins
Kyle Hadden et al. Geldanamycin, radicicol, and chimeric inhibitors of the Hsp90 Nterminal ATP binding site
EP1628667B1 (en) Method for treating diseases using hsp90-inhibiting agents in combination with antimitotics
US20080214617A1 (en) Carbamate compounds
EP1631267B1 (en) Method for treating diseases using hsp90-inhibiting agents in combination with antimetabolites
WO2005000211A2 (en) Method for treating diseases using hsp90-inhibiting agents in combination with platinum coordination complexes
US20050026893A1 (en) Method for treating diseases using HSP90-inhibiting agents in combination with immunosuppressants
US7378407B2 (en) Geldanamycin compounds and method of use
WO2005000212A2 (en) Method for treating diseases using hsp90-inhibiting agents in combination with nuclear export inhibitors
WO2005000214A2 (en) Method for treating diseases using hsp90-inhibiting agents in combination with antibiotics
US6887993B1 (en) 11-O-methylgeldanamycin compounds
US6855705B1 (en) 11-O-methylgeldanamycin compounds
US7241754B2 (en) 2-Desmethyl ansamycin compounds
WO2007074347A1 (en) 21-deoxymacbecin analogues useful as antitumor agents
AU2005249555A1 (en) Leptomycin compounds
JP2009536181A (ja) 癌治療用の１８，２１−ジデスオキシマクベシン誘導体
CA2456175A1 (en) Benzoquinone ansamycins
JP2010509307A (ja) ガンの治療のための１８，２１−ジデスオキシマクベシン誘導体
JP4717003B2 (ja) １１−ｏ−メチルゲルダナマイシン化合物
US6875863B1 (en) 11-O-methylgeldanamycin compounds

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued